Additional file 5 of Deciphering the antiviral mechanisms of Fangqin Qinggan decoction against influenza A virus: a multi-omics and machine learning approach
Liuweiwuling Tablet (LWWL) is a licensed Chinese patent medicine (approval number: Z20060238) included in the national health insurance for anti-inflammation of chronic HBV infection, whereas its anti
Background: Viral pneumonia is one of the most serious respiratory diseases, and multicomponent traditional Chinese medicines have been applied in the management of infected patients. As a representat
Liuweiwuling Tablet (LWWL) is a licensed Chinese patent medicine (approval number: Z20060238) included in the national health insurance for anti-inflammation of chronic HBV infection, whereas its anti
Objective: To explore the mechanism of MXSGD in treating viral lung injury induced by influenza A virus in mice based on Transcriptomics. Materials & Methods: The mice were divided into MXSGD group,
This is the supplementary data for the omics content mentioned in the ariticle named "Multiomic Profiling of Responses to Clinical and Novel Bisphosphonates Reveals Extraskeletal Effects on Ageing Rel